News

The following is the full transcript of an interview with Dr. Peter Marks, former head of FDA's Center for Biologics ...
Dr. Peter Marks, an ex-FDA vaccine official, is warning of a fundamental change at the agency—where vaccine skepticism now ...
Dr. Peter Marks announced his resignation from the U.S. Food and Drug Administration (FDA) as Director of CEBR (Center for ...
Biotech stocks plunge after Dr. Peter Marks resigns from FDA, citing disputes with RFK Jr. over vaccines and drug approvals.
A complete guide to lease accounting for healthcare organizations Making a successful transition to the latest lease accounting requirements such as ASC 842, IFRS 16 or GASB 87 can be a complicated ...
On Friday, Dr. Peter Marks announced his resignation from the U.S. Food and Drug Administration (FDA) as Director of CEBR (Center for Biologics Evaluation and Research) citing differences with ...